These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 10815791

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Clinical and laboratory study of an episode of cefotetan-induced severe hemolytic anemia.
    Franchini M, Piccoli PL, Gandini G, Giuffrida A, Bressan F, De Gironcoli M, Aprili G.
    Hematology; 2004 Feb; 9(1):65-9. PubMed ID: 14965871
    [Abstract] [Full Text] [Related]

  • 3. Cefotetan-induced immune hemolytic anemia following prophylaxis for cesarean delivery.
    Shariatmadar S, Storry JR, Sausais L, Reid ME.
    Immunohematology; 2004 Feb; 20(1):63-6. PubMed ID: 15373671
    [Abstract] [Full Text] [Related]

  • 4. Cefotetan-induced hemolytic anemia: a case report and review of the literature.
    Moes GS, MacPherson BR.
    Arch Pathol Lab Med; 2000 Sep; 124(9):1344-6. PubMed ID: 10975934
    [Abstract] [Full Text] [Related]

  • 5. Cefotetan-induced hemolytic anemia after perioperative prophylaxis.
    Martin ME, Laber DA.
    Am J Hematol; 2006 Mar; 81(3):186-8. PubMed ID: 16493619
    [Abstract] [Full Text] [Related]

  • 6. Cefotetan-induced immune hemolytic anemia due to the drug-adsorption mechanism.
    Eckrich RJ, Fox S, Mallory D.
    Immunohematology; 1994 Mar; 10(2):51-4. PubMed ID: 15945790
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Serology of antibodies to second- and third-generation cephalosporins associated with immune hemolytic anemia and/or positive direct antiglobulin tests.
    Arndt PA, Leger RM, Garratty G.
    Transfusion; 1999 Mar; 39(11-12):1239-46. PubMed ID: 10604252
    [Abstract] [Full Text] [Related]

  • 9. Cefotetan-induced immune hemolytic anemia.
    Chenoweth CE, Judd WJ, Steiner EA, Kauffman CA.
    Clin Infect Dis; 1992 Nov; 15(5):863-5. PubMed ID: 1445986
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Severe immune hemolytic anemia associated with prophylactic use of cefotetan in obstetric and gynecologic procedures.
    Garratty G, Leger RM, Arndt PA.
    Am J Obstet Gynecol; 1999 Jul; 181(1):103-4. PubMed ID: 10411803
    [Abstract] [Full Text] [Related]

  • 13. Fatal immune hemolytic anemia due to cefotetan.
    Garratty G, Nance S, Lloyd M, Domen R.
    Transfusion; 1992 Jul; 32(3):269-71. PubMed ID: 1557811
    [Abstract] [Full Text] [Related]

  • 14. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.
    Talano JA, Hillery CA, Gottschall JL, Baylerian DM, Scott JP.
    Pediatrics; 2003 Jun; 111(6 Pt 1):e661-5. PubMed ID: 12777582
    [Abstract] [Full Text] [Related]

  • 15. Cefotetan-Induced Hemolytic Anemia: Case Series and Review.
    Lim K, Tran H, Hirai-Yang A, Vakil N, Marks G, Klapper E.
    J Pharm Pract; 2019 Dec; 32(6):679-682. PubMed ID: 30189781
    [Abstract] [Full Text] [Related]

  • 16. Rare antibody-associated hemolytic transfusion reaction and transfusion-related acute lung injury: a case report.
    Beck TN, Young NG, Erickson ML, Prats I.
    BMC Surg; 2017 Apr 26; 17(1):48. PubMed ID: 28441942
    [Abstract] [Full Text] [Related]

  • 17. Fatal drug-induced immune hemolytic anemia due to cefotetan; A case study.
    Perkins J.
    Asian J Transfus Sci; 2008 Jan 26; 2(1):20-3. PubMed ID: 20041074
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.